Taking people in Dánia4. fázis
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Key facts
- Where
- Copenhagen, Herlev, Hillerød, Holbæk, Hvidovre, Køge, Nykøbing Falster, Rønne, Roskilde és Slagelse, DániaSee the 12 sites
- Phase
- 4. fázis
Where in Dánia
- Bispebjerg HospitalCopenhagen, DániaTaking people
- RigshospitaletCopenhagen, DániaTaking people
- Herlev and Gentofte HospitalHerlev, DániaTaking people
- Steno Diabetes Center CopenhagenHerlev, DániaTaking people
- Nordsjællands HospitalHillerød, DániaTaking people
- Holbæk SygehusHolbæk, DániaTaking people
- Hvidovre HospitalHvidovre, DániaTaking people
- Sjællands UniversitetshospitalKøge, DániaTaking people
- Nykøbing F. SygehusNykøbing Falster, DániaTaking people
- Bornholms HospitalRønne, DániaTaking people
- Sjællands UniversitetshospitalRoskilde, DániaTaking people
- Slagelse SygehusSlagelse, DániaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev and Gentofte Hospital
- Trial code
- NCT06642272
- Record updated
- 2026. szeptember 18.
- Original description
The aim of this clinical trial is investigate the comparative effectiveness of empagliflozin and dapagliflozin for the treatment of diabetes, chronic kidney disease, and heart failure.Read full original descriptionShow less
The aim of this clinical trial is investigate the comparative effectiveness of empagliflozin and dapagliflozin for the treatment of diabetes, chronic kidney disease, and heart failure.
Patients who are prescribed either empagliflozin or dapagliflozin, as part of daily clinical practice at the participating sites, will be included in the study. Treatment will be randomized automatically through the electronic health record software in clusters defined by time of day.
https://www.appletreestudy.com
Inclusion: Adults aged 18 years or more.
Exclusion: Incapabability of giving informed consent; Withdrawal of informed consent.